AusPAR: Pralatrexate

Australian Public Assessment Report

AusPAR

AusPAR: Pralatrexate [PDF, 1.03 MB]

AusPAR: Pralatrexate [Word, 1.03 MB]

Attachment: Extract from Clinical Evaluation Report: Pralatrexate [PDF, 1.91 MB]

Attachment: Extract from Clinical Evaluation Report: Pralatrexate [Word, 1.63 MB]

Attachment: Product Information for Pralatrexate [PDF, 163.36 KB]

Attachment: Product Information for Pralatrexate [Word, 83.27 KB]

Device/Product Name

Folotyn

Active ingredients

Pralatrexate

AusPAR Date

22 August 2017

Published

17 November 2020

Submission Number

PM-2011-03153-3-4

Submission Type

New chemical entity

Decision

Approved